CorTechs starts new phase of NIH grant for Alzheimer's

Brain imaging software developer CorTechs Labs has entered the second phase...Read more on AuntMinnie.comRelated Reading: CorTechs' NeuroQuant gets Brazilian clearance CorTechs names new CEO, sales VP CorTechs Labs inks licensing deal with UCSD Imaging Biometrics teams with CorTechs Labs Hitachi, CorTechs announce collaboration
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

CONCLUSIONS DEGs, including SORT1, CRYAB, PSMA1, and SDHA may have roles in the pathogenesis of PD through the MAPK, Wnt, and Notch signaling pathways. PMID: 32210219 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
PMID: 32209035 [PubMed - in process]
Source: Current Alzheimer Research - Category: Neurology Authors: Tags: Curr Alzheimer Res Source Type: research
CONCLUSIONS: WM pathology is strongly associated with impaired processing speed, and our results indicate that these impairments arise from WMH in the temporal and parieto-occipital regions. In MCI and AD patients with temporal WMH, processing speed impairments are especially prominent. The results of this study increase our knowledge of cognitive repercussions stemming from temporal and/or parieto-occipital WM pathology in healthy and pathological aging. PMID: 32209796 [PubMed - as supplied by publisher]
Source: Dementia and Geriatric Cognitive Disorders - Category: Psychiatry Tags: Dement Geriatr Cogn Disord Source Type: research
Authors: Khachaturian AS, Hayden KM, Devlin JW, Fleisher LA, Lock SL, Cunningham C, Oh ES, Fong TG, Fick DM, Marcantonio ER, Iyengar V, Rockwood K, Kuchel GA, Eckenhoff RG, MacLullich AMJ, Jones RN, Davis D, D'Antonio PM, Fargo KN, Albert MS, Williamson JD, Ling SM, Weiss J, Karlawish J, Petersen RC, Blazer DG, Khachaturian ZS, Inouye SK PMID: 32212231 [PubMed - as supplied by publisher]
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
Daily low-dose aspirin as prevention therapy takes another hit, this time for not reducing risk of Alzheimer's disease or cognitive impairment in a large randomized study.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Older men and women who took low-dose aspirin did not show improvements in memory or a lower risk of dementia.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Alzheimer ' s Disease Aspirin Dementia Heart Source Type: news
Authors: Candasamy M, Elhassan SA, Bhattamisra SK, Wong YH, Lim MS, Busthamin NA, Mohamad Ilni NB, Ng SS, Lim B, Ng SY, Ng WY Abstract Alzheimer's disease (AD) and type 2 diabetes mellitus (T2D) are two of the most commonly occurring diseases worldwide, especially among the elderly population. In particular, the increased prevalence of AD has imposed tremendous psychological and financial burdens on society. Growing evidence suggests both AD and T2D share many similar pathological traits. AD is characterized as a metabolic disorder whereby the glucose metabolism in the brain is impaired. This closely resembles the ...
Source: Panminerva Medica - Category: General Medicine Tags: Panminerva Med Source Type: research
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2020 E-Newsletter In this issue: NIDCR News Funding Opportunities NIH/HHS News Funding Notices Science Advances Subscribe to NICDR News Grantee News   NIDCR News CDC’s COVID-19 Guidance for Dental Settings  Dental health care personnel can find COVID-19-related information on the CDC’s Division of Oral Health website, which offers guidance and resources for clinics and health care facilities and recommen...
Source: NIDCR Science News - Category: Dentistry Source Type: news
Conclusions: In this study, we observed in middle- and old-aged individuals with neither dementia nor alcohol-related disorders that moderate lifetime alcohol intake was associated with lower cerebral AB deposition compared to a lifetime history of not drinking. Moderate lifetime alcohol intake may have a beneficial influence on AD by reducing pathological amyloid deposition rather than amyloid-independent neurodegeneration or cerebrovascular injury. The Study in Context: Report: 35% of worldwide dementia cases could be prevented by modifying these 9 modifiable risk factors Study: Drinking up to 5–8 glasses of wine...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Alzheimer-disease Alzheimers beer beta amyloid deposits brain protein dementia hard liquor mental acuity moderate drinking MRI neurodegeneration PET wine Source Type: blogs
IJERPH, Vol. 17, Pages 2261: Intention to Screen for Alzheimer’s Disease by Residential Locale International Journal of Environmental Research and Public Health doi: 10.3390/ijerph17072261 Authors: Lilah M. Besser Willa D. Brenowitz Juyoung Park Magdalena I. Tolea James E. Galvin A random digit dialing sample from Missouri (USA) was used to compare associations between psychosocial factors and Alzheimer’s disease (AD) screening intention based on residential locale. Linear regression associations between demographics and five psychosocial constructs (dementia knowledge, perceived screening b...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
More News: Alzheimer's | Brain | Brazil Health | Grants | Neurology | Radiology